Peer advisors polish resumes, build confidence

The peer advisor program is restarting in the Arts & Sciences Career Development office.

Around Cornell

Virtual screening IDs potential small molecule drugs for cancer immunotherapy

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell Medicine researchers.

Food waste solution wins top prize at hackathon

The hackathon included more than 150 undergraduate and graduate students from almost all of Cornell’s Ithaca campus schools and colleges.

Around Cornell

Grant will fund pain control research for critically ill children

Dr. Chani Traube, professor of pediatrics at Weill Cornell Medicine, has been awarded a $3.4 million grant from the National Institutes of Health for a clinical trial called Optimizing Pain Treatment in Children on Mechanical ventilation.

Potential drugs for cancer treatment may help tackle tuberculosis

Researchers in the College of Veterinary Medicine and colleagues have discovered that a protein complex that helps fight cancer cells also slows the growth of tuberculosis – a finding that could mean better treatments for both diseases.

Rookie entrepreneurs showcase BIG ideas

For undergraduate would-be entrepreneurs, this competition encourages examining micro- or macro-level problems and envisioning ways to fix them via innovative business ventures.

New genetic signature reveals a tropical virus on the move

For the first time, scientists have tracked the dispersion of the Oropouche virus in the Brazilian Amazon region, an important first step to control future outbreaks of a disease with more than 100,000 reported cases since the 1960s.

Discovery reveals how ovarian cancer disables immune cells

Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells – blocking the energy supply T cells depend on. The work points toward a promising new immunotherapy approach for ovarian cancer.

Benjamin Houlton reappointed CALS dean

The Cornell Board of Trustees’ Executive Committee voted Oct. 14 to approve a new five-year term, effective July 1, 2025.